Bivirkninger i form af smerter og arthralgi var overensstemmende med, at Kepivance behandlede patienter havde modtaget mindre opioide analgetika end placebo behandlede patienter (se Tabel 2).
The adverse reactions of pain and arthralgia were consistent with Kepivance treated patients having received less opioid analgesia than placebo-treated patients (see Table 2).